What's new

PSUSA/00001603/202408

PSUSA/00001603/202408

May 28, 2025 - 14:55
 0
PSUSA/00001603/202408
PSUSA/00001603/202408
Read More

Tags:

Previous Article

PSUSA/00000210/202408

Next Article

Human medicines European public assessment report (EPAR): Enhertu, trastuzumab d...

Related Posts

Human medicines European public assessment report (EPAR): Rystiggo, Rozanolixizumab, Date of authorisation: 05/01/2024, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

May 12, 2025  0

Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Date of authorisation: 08/01/2018, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR...

May 28, 2025  0

Nitrosamines EMEA-H-A5(3)-1490 - Questions and answers ...

May 19, 2025  0